|
인쇄하기
취소
|
Amlodipine camsylate comparable to amlodipine besylate in terms of efficacy and safety profiles
Published: 2004-06-28 07:00:00
Updated: 2004-06-28 07:00:00
Hanmi Pharm said on June 24 that its amlodipine camsylate is comparable to Pfizer's Norvasc (amlodipine besylate) in terms of efficacy and safety profiles, adding that the former protects amlodipine from heat and moisture better than besylate salt, based on the clinical results collected from seven university hospitals in Korea.
Prof. Shin Ik-gyun of Kachon Medical College, who conducted th...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.